Abvc Biopharma (ABVC) Accounts Payables (2010 - 2022)
Abvc Biopharma's (ABVC) quarterly Accounts Payables came in at $2085.0 in Q2 2022, down 58.69% YoY from $5047.0 in Q2 2021, and down 87.36% on a QoQ basis from $16497.0 in Q3 2021.
Abvc Biopharma (ABVC) Accounts Payables (2010 - 2022) Analysis & Trends
Abvc Biopharma (ABVC) has 10 years of Accounts Payables data on file, last reported at $2085.0 in Q2 2022.
- Quarterly Accounts Payables fell 58.69% year-over-year to $2085.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $2085.0 (down 58.69% YoY) and the FY2020 annual result came in at $23044.0, down 3.96% from the prior year.
- Accounts Payables slipped to $2085.0 in Q2 2022, from $16497.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $23995.0 in Q4 2019 to a low of $2085.0 in Q2 2022.
- A 4-year average of $14593.8 and a median of $15558.0 in 2019 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 72.41% in 2020, down 60.35% in 2020.
- Tracing ABVC's Accounts Payables over 4 years: stood at $23995.0 in 2019, then dropped by 3.96% to $23044.0 in 2020, then retreated by 28.41% to $16497.0 in 2021, then slumped by 87.36% to $2085.0 in 2022.
- The last three Accounts Payables figures came in at $2085.0 (Q2 2022), $16497.0 (Q3 2021), and $5047.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2,085.00 |
| Sep 30, 2021 | 16,497.00 |
| Jun 30, 2021 | 5,047.00 |
| Mar 31, 2021 | 10,334.00 |
| Dec 31, 2020 | 23,044.00 |
| Sep 30, 2020 | 23,074.00 |
| Jun 30, 2020 | 7,812.00 |
| Dec 31, 2019 | 23,995.00 |
| Sep 30, 2019 | 13,383.00 |
| Jun 30, 2019 | 19,703.00 |
| Mar 31, 2019 | 15,558.00 |
| Dec 31, 2016 | 6.50 Mn |
| Sep 30, 2016 | 18,370.00 |
| Jun 30, 2016 | 6.50 Mn |
| Sep 30, 2015 | 300,000.00 |
| Sep 30, 2014 | 18,030.00 |
| Jun 30, 2012 | 24,786.00 |
| Mar 31, 2012 | 18,463.00 |
| Dec 31, 2011 | 40,030.00 |
| Sep 30, 2011 | 27,945.00 |